KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) EBIT (2016 - 2026)

Medtronic (MDT) has disclosed EBIT for 13 consecutive years, with $1.5 billion as the latest value for Q1 2026.

  • Quarterly EBIT fell 11.06% to $1.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.0 billion through Jan 2026, up 8.24% year-over-year, with the annual reading at $6.0 billion for FY2025, 15.77% up from the prior year.
  • EBIT hit $1.5 billion in Q1 2026 for Medtronic, down from $1.7 billion in the prior quarter.
  • In the past five years, EBIT ranged from a high of $1.7 billion in Q4 2025 to a low of $1.1 billion in Q2 2024.
  • Historically, EBIT has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2025.
  • Biggest five-year swings in EBIT: plummeted 32.72% in 2024 and later skyrocketed 36.37% in 2025.
  • Year by year, EBIT stood at $1.4 billion in 2022, then fell by 4.56% to $1.3 billion in 2023, then increased by 19.03% to $1.6 billion in 2024, then rose by 5.71% to $1.7 billion in 2025, then fell by 13.17% to $1.5 billion in 2026.
  • Business Quant data shows EBIT for MDT at $1.5 billion in Q1 2026, $1.7 billion in Q4 2025, and $1.4 billion in Q3 2025.